Is FDA Addicted to User Fees?

A column in today's Washington Post ponders whether FDA's increasing reliance on user fees makes the agency too beholden to industry. It discusses this in the context of the pending reauthorization of the drug user fee act.

April 3, 2007

1 Min Read
Is FDA Addicted to User Fees?

Transforming FDA LogoA column in today's Washington Post ponders whether FDA's increasing reliance on user fees makes the agency too beholden to industry. It discusses this in the context of the pending reauthorization of the drug user fee act. But you can bet these same issues will come up when it comes time for MDUFMA to be reauthorized.The reality is, Congress, even when controlled by the Democrats, isn't willing to fully fund what it takes for FDA to accomplish its mission. Therefore, user fees are inevitable. The ongoing reforms to the agency's postmarket surveillance system should hopefully take care of many of the safety issues that concern those who are against user fees.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like